IMPORTANCE OF CLINICAL OUTCOME ASSESSMENT (COA) DATA IN THE EVALUATION OF MEDICINES FOR THE TREATMENT OF RESTLESS LEGS SYNDROME (RLS): A REVIEW OF THE LABELS OF MEDICINES APPROVED BY THE FDA AND THE EMA

Perrier L.; Emery M.; Anfray C.; Acquadro C.

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >IMPORTANCE OF CLINICAL OUTCOME ASSESSMENT (COA) DATA IN THE EVALUATION OF MEDICINES FOR THE TREATMENT OF RESTLESS LEGS SYNDROME (RLS): A REVIEW OF THE LABELS OF MEDICINES APPROVED BY THE FDA AND THE EMA

【24h】

IMPORTANCE OF CLINICAL OUTCOME ASSESSMENT (COA) DATA IN THE EVALUATION OF MEDICINES FOR THE TREATMENT OF RESTLESS LEGS SYNDROME (RLS): A REVIEW OF THE LABELS OF MEDICINES APPROVED BY THE FDA AND THE EMA

机译：临床结果评估（COA）数据在治疗焦点腿综合征的评估中的重要性（RLS）：对FDA和EMA批准的药物标签审查

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2017年第5期|共1页
作者
Perrier L.; Emery M.; Anfray C.; Acquadro C.;
展开▼
作者单位

Mapi Res Trust Lyon France;

Mapi Res Trust Lyon France;

Mapi Res Trust Lyon France;

Mapi Lyon France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. IMPORTANCE OF CLINICAL OUTCOME ASSESSMENT (COA) DATA IN THE EVALUATION OF MEDICINES FOR THE TREATMENT OF RESTLESS LEGS SYNDROME (RLS): A REVIEW OF THE LABELS OF MEDICINES APPROVED BY THE FDA AND THE EMA [J] . Perrier L., Emery M., Anfray C., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：临床结果评估（COA）数据在治疗焦点腿综合征的评估中的重要性（RLS）：对FDA和EMA批准的药物标签审查
2. Traditional Chinese medicine herbal preparations in restless legs syndrome (RLS) treatment: A review and probable first description of RLS in 1529 [J] . YanX., WangW.-D., WaltersA.S., Sleep medicine reviews . 2012,第6期

机译：中草药制剂在腿不安定综合征（RLS）治疗中的应用：1529年RLS的回顾和首次描述
3. Improving sleep for patients with restless legs syndrome. Part II: meta-analysis of vibration therapy and drugs approved by the FDA for treatment of restless legs syndrome [J] . Fred Burbank, Mark J Buchfuhrer, Branko Kopjar Journal of Parkinsonism and Restless Legs Syndrome . 2013,第2期

机译：改善腿不安定综合征患者的睡眠。第二部分：振动疗法和FDA批准用于治疗躁动性腿综合征的药物的荟萃分析
4. Clinical Evaluation of the Integrated Traditional Chinese Medicine with Western Medicine on Treatment of Severe Acute Respiratory Syndrome (SARS) [C] . LI Xiuhui, ZHANG Ke, Hu Jianhua, Proceedings of International Science Symposium on SARS . 2003

机译：中西医结合治疗严重急性呼吸系统综合症（SARS）的临床评价
5. A comprehensive assessment of mucositis due to radiation for head and neck cancer: Pathophysiology, clinical and patient-reported outcomes, and a proposal for a novel treatment based on ayurvedic medicine. [D] . Ramnath, Rajesh. 2016

机译：头颈部癌放疗引起的粘膜炎的综合评估：病理生理，临床和患者报告的结局，以及基于阿育吠陀医学的新型治疗方案的建议。
6. Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease) [O] . William G. Ondo, Frank Grieger, Kimberly Moran, 2016

机译：两项临床试验数据的事后分析评估了躁动性腿综合征（Willis-Ekbom病）患者的国际躁动性腿综合征总和得分的最小临床意义
7. Improving sleep for patients with restless legs syndrome. Part II: meta-analysis of vibration therapy and drugs approved by the FDA for treatment of restless legs syndrome [O] . Fred Burbank, Mark Buchfuhrer, Branko Kopjar, 2013

机译：改善睡眠患者睡眠综合征。第II部分：FDA批准的振动治疗和药物治疗焦点腿综合征的振动治疗和药物的荟萃分析

IMPORTANCE OF CLINICAL OUTCOME ASSESSMENT (COA) DATA IN THE EVALUATION OF MEDICINES FOR THE TREATMENT OF RESTLESS LEGS SYNDROME (RLS): A REVIEW OF THE LABELS OF MEDICINES APPROVED BY THE FDA AND THE EMA

著录项

相似文献

相关主题

期刊订阅